Trevi Therapeutics (TRVI) has caught the attention of investors after recent updates on its chronic cough clinical programs. The company is moving ahead with Phase 3 plans for IPF-related chronic ...
Trevi Therapeutics recently reported its third quarter earnings, highlighting a net loss of US$11.8 million and progress toward advancing its chronic cough drug Haduvio into Phase 3 clinical trials.
The Big Mamma Group, as the name suggests, does not do things in a small way. Founded in 2015 by Frenchmen Victor Lugger and Tigrane Seydoux, the group now has some 30 restaurants around Europe, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback